The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Hypoxia-inducible Factor 1α (HIF-1α)-mediated Hypoxia Increases BACE1 Expression and β-Amyloid Generation
Open accessAbstract
The incidence of Alzheimer disease (AD) and vascular dementia is greatly increased following cerebral ischemia and stroke in which hypoxic conditions occur in affected brain areas. beta-Amyloid peptide (Abeta), which is derived from the beta-amyloid precursor protein (APP) by sequential proteolytic cleavages from beta-secretase (BACE1) and presenilin-1 (PS1)/gamma-secretase, is widely believed to trigger a cascade of pathological events culminating in AD and vascular dementia. However, a direct molecular link between hypoxic insults and APP processing has yet to be established. Here, we demonstrate that acute hypoxia increases the expression and the enzymatic activity of BACE1 by up-regulating the level of BACE1 mRNA, resulting in increases in the APP C-terminal fragment-beta (betaCTF) and Abeta. Hypoxia has no effect on the level of PS1, APP, and tumor necrosis factor-alpha-converting enzyme (TACE, an enzyme known to cleave APP at the alpha-secretase cleavage site). Sequence analysis, mutagenesis, and gel shift studies revealed binding of HIF-1 to the BACE1 promoter. Overexpression of HIF-1alpha increases BACE1 mRNA and protein level, whereas down-regulation of HIF-1alpha reduced the level of BACE1. Hypoxic treatment fails to further potentiate the stimulatory effect of HIF-1alpha overexpression on BACE1 expression, suggesting that hypoxic induction of BACE1 expression is primarily mediated by HIF-1alpha. Finally, we observed significant reduction in BACE1 protein levels in the hippocampus and the cortex of HIF-1alpha conditional knock-out mice. Our results demonstrate an important role for hypoxia/HIF-1alpha in modulating the amyloidogenic processing of APP and provide a molecular mechanism for increased incidence of AD following cerebral ischemic and stroke injuries.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“BACE1 levels and activity increase in response to hypoxia, energy disruption, and mitochondrial stress, owing to HIF‐1 binding the BACE1 promoter.”
From BACE1: More than just a β‐secretase (2022) · cites this paper as [49]
In the citing paper
“reduced blood flow increases Aβ production (13, 14).”
From Amyloid β oligomers constrict human capillaries in Alzheimer's disease via signaling to pericytes (2019) · cites this paper as [14]
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
Purification and cloning of amyloid precursor protein β-secretase from human brain
Sinha, S., Anderson, J. P., Barbour, R., Basi, G. S., Caccavello, R., Davis, D., Doan, M., Dovey, H. F., Frigon, N., Hong, J., et al. (1999) · Nature · doi:10.1038/990114 · Cited by 1,612
HIF‐1α is required for solid tumor formation and embryonic vascularization
Ryan, H. E., Lo, J., & Johnson, R. S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3005 · Cited by 1,579
Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity
Yan, R., Bienkowski, M. J., Shuck, M. E., Miao, H., Tory, M. C., Pauley, A. M., Brashler, J. R., Stratman, N. C., Mathews, W. R., Buhl, A. E., et al. (1999) · Nature · doi:10.1038/990107 · Cited by 1,438
BACE1 is the major β-secretase for generation of Aβ peptides by neurons
Cai, H., Wang, Y., McCarthy, D. B., Wen, H., Borchelt, D., Price, D. L., & Wong, P. C. (2001) · Nature Neuroscience · doi:10.1038/85064 · Cited by 1,087
Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase
Hussain, I., Powell, D., Howlett, D. R., Tew, D. G., Meek, T. D., Chapman, C., Gloger, I. S., Murphy, K. E., Southan, C. D., Ryan, D. M., et al. (1999) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0811 · Cited by 1,080
Lammich, S., Kojro, E., Postina, R., Gilbert, S., Pfeiffer, R., Jasionowski, M., Haass, C., & Fahrenholz, F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3922 · Cited by 975
Buxbaum, J. D., Liu, K.-N., Luo, Y., Slack, J. L., Stocking, K. L., Peschon, J. J., Johnson, R. S., Castner, B. J., Cerretti, D. P., & Black, R. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.27765 · Cited by 952
Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease
Yang, L.-B., Lindholm, K., Yan, R., Citron, M., Xia, W., Yang, X.-L., Beach, T., Sue, L., Wong, P., Price, D., et al. (2003) · Nature Medicine · doi:10.1038/nm0103-3 · Cited by 729
Flagged first, then by citations
1 of the 48 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–400 of 438
İş, Ö., Min, Y., Wang, X., Oatman, S. R., Daniel, A. A., & Ertekin‐Taner, N. (2024) · Glia · doi:10.1002/glia.24652 · Cited by 13
Ghotbeddin, Z., Tabandeh, M. R., Borujeni, M. P., Truski, F. F., Pour, M. R. Z. G., & Tabrizian, L. (2021) · Brain and Behavior · doi:10.1002/brb3.2078 · Cited by 12
Effects of Blood Pressure Changes on Alzheimer’s Disease
Feldstein, C. A. (2010) · Neuroepidemiology · doi:10.1159/000316872 · Cited by 12
Misery perfusion and amyloid deposition in atherosclerotic major cerebral artery disease
Yamauchi, H., Kagawa, S., Takahashi, M., Oishi, N., Ono, M., & Higashi, T. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101762 · Cited by 11
Singrang, N., Nopparat, C., Panmanee, J., & Govitrapong, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105225 · Cited by 11
BACE1 as an early biomarker and its relevance to risk factors for Alzheimer’s disease
Ohno, M. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111475 · Cited by 12
Activation of the hypoxia response protects mice from amyloid-β accumulation
Ollonen, T., Kurkela, M., Laitakari, A., Sakko, S., Koivisto, H., Myllyharju, J., Tanila, H., Serpi, R., & Koivunen, P. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04460-6 · Cited by 11
Viable mouse gene ablations that robustly alter brain Aβ levels are rare
Toyn, J. H., Lin, X.-A., Thompson, M. W., Guss, V. L., Meredith, J. E., Sankaranarayanan, S., Barrezueta, N. X., Corradi, J., Majumdar, A., Small, D. L., et al. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-143 · Cited by 11
β-Secretase 1 and its Naturally Occurring Anti-Sense RNA are Down-Regulated in Gastric Cancer
Esfandi, F., Ghafouri‐Fard, S., Oskooei, V. K., & Taheri, M. N. (2019) · Pathology & Oncology Research · doi:10.1007/s12253-019-00621-4 · Cited by 11
Wang, S., & Jia, J. (2009) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30968 · Cited by 12
Hypoxia and its Emerging Therapeutics in Neurodegenerative, Inflammatory and Renal Diseases
Bhatia, D., Ardekani, M. S., Shi, Q., & Movafagh, S. (2017) · Hypoxia and Human Diseases · doi:10.5772/66089 · Cited by 17
Nagayama, T., Yagishita, S., Shibata, M., Furuno, A., Saito, T., Saido, T. C., Wakatsuki, S., & Araki, T. (2024) · Neuroscience Research · doi:10.1016/j.neures.2024.03.003 · Cited by 10
Cheng, Y., Lin, L., Huang, P., Zhang, J., Wang, Y., & Pan, X. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003103 · Cited by 10
Park, J. S., Choe, K., Ahmad, R., Park, H. Y., Kang, M. H., Park, T. J., & Kim, M. O. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.06.001 · Cited by 11
Antihypertensives, angiotensin, glucose and Alzheimer’s disease
Nelson, L., Tabet, N., Richardson, C., & Gard, P. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.13.32 · Cited by 11
Yatawara, C., Ng, K. P., Guevarra, A. C., Wong, B. Y. X., Yong, T., & Kandiah, N. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200311 · Cited by 10
Transcriptional regulation of α1H T-type calcium channel under hypoxia
Sellak, H., Zhou, C., Liu, B., Chen, H., Lincoln, T., & Wu, S. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00210.2014 · Cited by 10
Sivanesan, S., Mundugaru, R., & Rajadas, J. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/2764831 · Cited by 10
Xiong, Q., Li, F., Chi, H., Yang, Y., Li, M., Liu, Y., Zhang, Y., Leng, B., Qi, X., Sun, H., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad764 · Cited by 10
Self-citationTang, X., Wang, L., Feng, Q., Hu, H., Zhu, Y., Liao, Z., Ding, Z., & Xu, X. (2025) · Scientific Reports · doi:10.1038/s41598-024-82769-x · Cited by 9
Zhao, M., Tanourlouee, S. B., McCracken, S., & Williams, P. R. (2025) · Neurophotonics · doi:10.1117/1.nph.12.s2.s22805 · Cited by 9
Alzheimer's Factors in Ischemic Brain Injury
Pluta, R. M., & Jaboski, M. (2012) · InTech eBooks · doi:10.5772/27205 · Cited by 9
Lee, J.-I., Lim, J. S., Hong, J., Kim, S., Lee, S., Ji, H. D., Won, K. S., Song, B., & Kim, H. W. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262224 · Cited by 10
Serebrovska, Z. O., Xi, L., Fedoriuk, M., Dosenko, V., Shysh, A. M., Khetsuriani, M., Porkhalo, D., Savchenko, A., Goncharov, S. V., Utko, N., et al. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149301 · Cited by 8
Traumatic Brain Injury and Alzheimer’s Disease: A Shared Neurovascular Hypothesis
Cognacq, G., Attwood, J. E., & DeLuca, G. C. (2025) · Neuroscience Insights · doi:10.1177/26331055251323292 · Cited by 9
Xie, G., Jiang, G., Huang, L., Sun, S., Wan, Y., Li, F., Wu, B., Zhang, Y., Li, X., Xiong, B., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18060790 · Cited by 10
Self-citationThe heart–brain axis: neurocognitive frailty in heart failure
Bolaji, O., Bahar, Y., Lohana, S., Bahar, Y., Lawrence, I., & Mazimba, S. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13257-z · Cited by 8
Zhao, Y., Vališ, M., Wang, X., Nepovimová, E., Wu, Q., & Kuča, K. (2024) · Mycotoxin Research · doi:10.1007/s12550-024-00525-6 · Cited by 8
The role of cerebral blood flow in the pathogenesis of Alzheimer's Disease Dementia
Desai, B., Edwards, O., & Beishon, L. (2024) · Aging and Health Research · doi:10.1016/j.ahr.2024.100188 · Cited by 7
Martínez, A. (2024) · Medicinal Chemistry Research · doi:10.1007/s00044-024-03278-0 · Cited by 8
Adapting to Dementia in Society: A Challenge for Our Lifetimes and a Charge for Public Health
D’Alton, S., Hunter, S., Whitehouse, P. J., Brayne, C., & George, D. R. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140213 · Cited by 8
Yatawara, C., Zailan, F. Z., Chua, E. V., Lim, L. L. H., da Silva, E. F., Wang, J. S., Ng, A. S. L., Ng, K. P., & Kandiah, N. (2021) · Clinical Interventions in Aging · doi:10.2147/cia.s290055 · Cited by 8
Kaufmann, C. N., Bondi, M. W., Thompson, W. K., Spira, A. P., Ancoli‐Israel, S., & Malhotra, A. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab164 · Cited by 9
Gene Expression Profiles of APP and BACE1 in Tg SOD1G93A Cortical Cells
Spadoni, O., Crestini, A., Piscopo, P., Malvezzi‐Campeggi, L., Carunchio, I., Pieri, M., Zona, C., & Confaloni, A. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9356-8 · Cited by 7
Β-Amyloid Deposits in Young COVID PatientsPreprint
Rhodes, C. H., Priemer, D. S., Karlovich, E., Perl, D. P., & Goldman, J. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4003213 · Cited by 8
Sharma, V., Verma, R., & Singh, T. G. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10520-4 · Cited by 8
Sivagurunathan, N., & Latchoumycandane, C. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230418114446 · Cited by 8
Inverse correlation between Alzheimer’s disease and cancer from the perspective of hypoxia
Su, Z., Zhang, G., Li, X., & Zhang, H. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.07.002 · Cited by 7
Differential roles of Aβ processing in hypoxia-induced axonal damage
Christianson, M. G., & Lo, D. C. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.02.027 · Cited by 7
Levin, O. S., & Васенина, Е. Е. (2017) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-017-0513-0 · Cited by 8
Maki, T., Sawahata, M., Akutsu, I., Amaike, S., Hiramatsu, G., Uta, D., Izuo, N., Shimizu, T., Irie, K., & Kume, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113259 · Cited by 7
Baranova, K. A., Rybnikova, E. A., & Самойлов, М. О. (2017) · Neurochemical Journal · doi:10.1134/s1819712417020027 · Cited by 7
Rybnikova, E. A., Baranova, K. A., Глущенко, Т. С., Ветровой, О. В., Sidorova, M., & Портніченко, В. І. (2014) · Fìzìologìčnij žurnal · doi:10.15407/fz59.06.088 · Cited by 7
Hu, X., Li, Y.-B., Qi, S., Zhang, Q., Ren, T., Meng, W., & Zhao, Q. (2016) · Journal of Functional Foods · doi:10.1016/j.jff.2016.10.012 · Cited by 7
Developing theragnostics for Alzheimer's disease: Insights from cancer treatment
Lee, H., Choi, H.-J., Jeong, Y. J., Na, Y., Hong, J. T., Han, J. M., Hoe, H., & Lim, K. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131925 · Cited by 6
Lizcano, F., Sanabria, D., & Aviles, E. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1622186 · Cited by 8
Lu, L.-P., Chang, W.-H., Huang, J., Peng, T., & Tsai, G. E. (2022) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220025 · Cited by 6
Metabolic Plasticity in Developing and Aging Brain
Salmina, A. B. (2023) · Neurochemical Journal · doi:10.1134/s1819712423030157 · Cited by 6
Pepperberg, D. R. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190476 · Cited by 6
Kong, W., & Zang, Y. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.959472 · Cited by 6
Strutynska, N. A., Strutynskyi, R. B., Chorna, S. V., Semenykhina, O. M., Mys', L., Moibenko, O. O., & Sahach, V. F. (2014) · Fìzìologìčnij žurnal · doi:10.15407/fz59.06.003 · Cited by 6
Blocking α1 Adrenergic Receptor as a Novel Target for Treating Alzheimer’s Disease
Pan, X., Lei, Z., Chen, J., Jia, C., Deng, J., Liu, Y., Luo, X., Wang, L., Zi, D., Wang, Z., et al. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00411 · Cited by 5
Alzheimer’s Disease and Diabetes
Brent, D. A., Gary, L., Aboud, Z., & Gordon, W. (2013) · InTech eBooks · doi:10.5772/54913 · Cited by 6
Neuroimaging of sleep disorders
Nofzinger, E. A., Maquet, P., & Thorpy, M. J. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139088268.025 · Cited by 5
Sharifulina, S., Khaitin, A. M., Guzenko, V., Kalyuzhnaya, Y. N., Dzreyan, V., Logvinov, A., DOBAEVA, N. M., Li, Y., Chen, L., He, B., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10102655 · Cited by 5
Xu, R., Yang, X., Yao, K., Yang, K.-F., Hu, L., Zhan, X.-Y., Zhou, M.-S., & Jia, H. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189386 · Cited by 5
Botchway, B. O. A., Kousiappa, I., Koupparis, A. M., Papacostas, S., Georgiades, S., Bashiardes, S., Hadjisavvas, A., Loucaides, G., Adamou, A., Christou, Y. P., et al. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261428636 · Cited by 5
Dysfunction of the neurovascular unit as a temporal driver in Alzheimer’s pathogenesis
Wang, L., Han, L., & Liu, S. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00548-2 · Cited by 6
Huang, S., Nunez, J., Toresco, D. L., Wen, C., Slotabec, L. A., Wang, H., Zhang, H., Rouhi, N., Adenawoola, M. I., & Li, J. (2025) · The FASEB Journal · doi:10.1096/fj.202402725rr · Cited by 4
Maladie d’Alzheimer et anesthésie : relations potentielles et implications cliniques
André, D., Dartigues, J.-F., & Sztark, F. (2010) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/j.annfar.2010.10.013 · Cited by 4
Guo, Y., Tan, C.-C., Tan, M.-S., Tan, L., & Xu, W. (2024) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2024.40 · Cited by 4
Amyloid Beta–Mediated Neurovascular Toxicity in Alzheimer’s Disease
Banerjee, S., & Banerjee, S. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3662-6_26 · Cited by 4
Metabolic Plasticity of a Developing and Aging Brain
Salmina, A. B. (2023) · Нейрохимия · doi:10.31857/s1027813323030159 · Cited by 4
Multifactorial glial responses and their contributions to Alzheimer's disease continuum
Hijioka, M., Manabe, T., & Saito, T. (2023) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12745 · Cited by 4
Truski, F. F., Ghotbeddin, Z., Tabandeh, M. R., & Borujeni, M. P. (2020) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.11.4.1787.1 · Cited by 4
Jeong, H., Pan, Y., Akhter, F., Volkow, N. D., Zhu, D., & Du, C. (2024) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x241304893 · Cited by 5
Neurochemical Aspects of Neurodegenerative Diseases
Farooqui, A. A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6652-0_8 · Cited by 3
Zou, Y., Yu, L., Yu, W., Du, Y., Shi, R., Zhang, M., Duan, J., Deng, Y., Tu, Q., Dai, R., et al. (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000351669 · Cited by 3
Vassar, R. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00003-4 · Cited by 3
Integrating Data for Modeling Biological Complexity
Hunter, S., & Brayne, C. (2013) · Springer eBooks · doi:10.1007/978-3-642-30574-0_52 · Cited by 3
Qian, L., Kasas, L., Milne, M., Rawashdeh, O., Marks, N., Sharma, A., Bellingham, M. C., & Coulson, E. J. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.12.989848 · Cited by 3
Advances in natural medicinal plant-based interventions against hypoxia-related neuroinflammation
Li, Q.-Y., Wang, C., Liu, W.-J., Bu, X.-S., Zheng, Y.-D., Meng, X., Shi, X.-F., & Yang, J.-L. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.121161 · Cited by 2
Srb, N., Milostić-Srb, A., Sarić, L., Holik, D., Šapina, M., Fureš, R., Talapko, J., Škrlec, I., Katalinić, D., & Kovačić, B. (2026) · Medical Sciences · doi:10.3390/medsci14010061 · Cited by 2
APP as an innate injury-response molecule
Olmsted, Z. T., & Sofroniew, M. V. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107361 · Cited by 3
Mikołajczak, K., Chmiel, J., & Leszek, J. (2026) · Cells · doi:10.3390/cells15121111 · Cited by 2
Hypoxic-Hyperoxic Training in Dementia
Tsagkaris, C., Rayan, R. Α., Konstantara, E., Matiashova, L., & Danilchenko, V. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_17 · Cited by 2
Coenzyme Q and Age-Related Neurodegenerative Disorders: Parkinson and Alzheimer Diseases
Alcain, F. J., Domínguez, J., Durán‐Prado, M., & Vaamonde, J. (2020) · Springer eBooks · doi:10.1007/978-3-030-45642-9_12 · Cited by 2
PKCε inhibition prevents ischemia‑induced dendritic spine impairment in cultured primary neurons
Ge, C., Wang, X., Wang, Y.-H., Lei, L., Song, G., Qian, M., & Wang, S. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.11851 · Cited by 2
Jeong, H., Pan, Y., Akhter, F., Volkow, N. D., Zhu, D., & Du, C. (2023) · Research Square · doi:10.21203/rs.3.rs-3579916/v1 · Cited by 2
Yin, T., Wang, G., Ma, Z., Wang, L., Chen, R., Xiang, K., Tan, L., Wang, Y., Chong, M., Liang, Y., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.10.637339 · Cited by 2
Carrera, I., Naidoo, V., Corzo, L., Martínez-Iglesias, O. A., & Cacabelos, R. (2025) · Genes · doi:10.3390/genes16101214 · Cited by 1
Intracranial atherosclerosis increases risk of incident dementia in middle-aged general population
Zhang, D., Han, F., Yuan, J., Zhou, L., Yao, M., Li, M. L., Jin, Z., Zhang, S., Cui, L., Ni, J., et al. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003837 · Cited by 1
Amyloid-β fibrils accumulated in preeclamptic placentas suppress cytotrophoblast syncytialization
Nishioka, K., Ikezaki, M., Iwahashi, N., Arakawa, M., Fukushima, M., Mori, N., Mizoguchi, M., Horiuchi-Tanizaki, Y., Fujino, M., Tomiyama, T., et al. (2026) · Life Science Alliance · doi:10.26508/lsa.202503453 · Cited by 2
Thelwell, J., & Johnson, A. J. (2026) · Neuroglia · doi:10.3390/neuroglia7030018 · Cited by 1
Tarumi, T. (2012) · Journal of Gerontology & Geriatric Research · doi:10.4172/2167-7182.1000e111 · Cited by 1
Presenilins Interactome in Alzheimer’s Disease and Pathological Ageing
Wężyk, M., & Żekanowski, C. (2017) · InTech eBooks · doi:10.5772/intechopen.68748 · Cited by 1
Association of G/C (rs638405) Polymorphism in β-secretase Gene with Alzheimer's Disease.
Chashmpoosh, M., Babaahmadi, H., Mousavidehmordi, R., Shalbafan, B., Mohammadi, A., & Kheirollah, A. (2018) · Europe PMC (PubMed Central) · Cited by 1
Anti-amyloid β hydrophobic peptides in Alzheimer’s disease: biomarkers and therapeutic potential
Gutiérrez‐Merino, C. (2025) · Exploration of neuroscience · doi:10.37349/en.2025.100672 · Cited by 2
Rybnikova, E. A., Baranova, K. A., & Zenko, M. Y. (2025) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-025-06436-5 · Cited by 1
COVID-19 and Alzheimer's Disease: A Review of Mechanisms and Pathophysiology
Mohammadkhanizadeh, A., & Karimzadeh, F. (2021) · The Neuroscience Journal of Shefaye Khatam · doi:10.52547/shefa.9.2.151 · Cited by 1
Prestroke Cognitive Function and Cerebrovascular Disease
O’Sullivan, M. (2007) · Stroke · doi:10.1161/strokeaha.107.496679 · Cited by 1
Overexpression of HIF-2α in Protected Regions of Alzheimer’s disease Resilient CasesPreprint
Mitri, V. (2020) · medRxiv · doi:10.1101/2020.08.27.20180331 · Cited by 1
Sharifulina, S., Guzenko, V., Logvinov, A., Khaitin, A. M., Kalyuzhnaya, Y. N., DOBAEVA, N. M., Li, Y., Chen, L., He, B., & Demyanenko, S. V. (2022) · Preprints.org · doi:10.20944/preprints202205.0184.v1
Neuroimaging of cognitive effects in obstructive sleep apnea
THOMAS, R. J., & Chan, S. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139088268.036
Cerebrospinal fluid biomarkers for differentiating between Alzheimer’s disease and Vascular dementia
Bjerke, M. (2011) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Flavonoids as regulators of amyloid precursor protein processing
Cox, C. J. (2014) · The University of Bath Online Publications Store (The University of Bath)
Hoffman, P., & Wong, P. (2011)
Carvalho, C. (2013) · Estudo Geral (Universidade de Coimbra)
Fibrin Formation and Dissolution in the Progression of Amyloid-Beta Pathology in Alzheimer's Disease
Paul, J. (2025) · Digital Commons - RU (Rockefeller University) · doi:10.48496/m50g-qv97
Metadata
- Authors
- Zhang, X., Zhou, K., Wang, R., Cui, J., Lipton, S. A., Liao, F.-F., Xu, H., & Zhang, Y.-W.
- Affiliations
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Shanghai Jiao Tong University (CN)
- Corresponding author
- Xu, Huaxi
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-04
- Volume
- 282
- Issue
- 15
- Pages
- 10873-10880
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2030333049
- Semantic Scholar
- eb4c044d3442f536df662e6d66780f400d3ccdf9
- Cited by
- 436
- References
- 48
- Citations by year
- 2026: 22 · 2025: 27 · 2024: 26 · 2023: 18 · 2022: 23 · 2021: 23 · 2020: 13 · 2019: 16 · 2018: 24 · 2017: 15 · 2016: 20 · 2015: 28 · 2014: 34 · 2013: 22 · 2012: 29
- FWCI
- 14.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (R01AG030197, R01 AG021173)
- National Institute of Neurological Disorders and Stroke (R01NS046673, R01NS054880)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- hypoxia, HIF-1α, BACE1, amyloid-beta, Alzheimer's disease, vascular dementia, APP processing, beta-secretase, cerebral ischemia, stroke, hippocampus, cerebral cortex
- MeSH terms
- Animals, Base Sequence, Binding Sites, Brain, Cell Line, Humans, Molecular Sequence Data, Promoter Regions, Genetic, Time Factors, Transcription, Genetic, Cell Hypoxia, Up-Regulation, Gene Expression Regulation, Enzymologic, Amyloid beta-Peptides, Aspartic Acid Endopeptidases, Mice, Knockout, Mice, Hypoxia-Inducible Factor 1, alpha Subunit, Amyloid Precursor Protein Secretases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
